Xu, N., Chen, Y., Gao, Z., Wang, C., Pan, F., Shen, Y., Zhu, L., Li, W., Zhao, C., Gu, Z., Mao, T., Fang, W. (2026). A phase II, single-arm trial of adebrelimab plus nab-paclitaxel and carboplatin as first-line therapy for advanced thymic carcinoma: Interim efficacy and safety results.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20171